The Enterprise Value as of September 2024 (TTM) for Exscientia plc (EXAI) is 385.40M

According to Exscientia plc’s latest financial reports and current stock price. The company's current Enterprise Value is 385.40M. This represents a change of -0.28% compared to the average of 386.46M of the last 4 quarters.

Exscientia plc (EXAI) Historical Enterprise Value (quarterly & annually)

How has EXAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Exscientia plc over the last ten years is 1.42B. The current 385.40M Enterprise Value has changed 2.61% with respect to the historical average. Over the past ten years (40 quarters), EXAI's Enterprise Value was at its highest in in the March 2021 quarter at 2.22T. The Enterprise Value was at its lowest in in the December 2022 quarter at 61.31M.

Exscientia plc (EXAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Exscientia plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Exscientia plc (EXAI) Average Enterprise Value

How has EXAI Enterprise Value performed in the past?

The current Enterprise Value of Exscientia plc (EXAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Exscientia plc (EXAI) Enterprise Value vs. Peers

How is EXAI’s Enterprise Value compared to its peers?

Exscientia plc’s Enterprise Value is less than VectivBio Holding AG (848.58M), greater than Zura Bio Limited (74.94M), greater than Elevation Oncology, Inc. (6.59M), less than Icosavax, Inc. (713.87M), less than Recursion Pharmaceuticals, Inc. (1.51B), greater than Atea Pharmaceuticals, Inc. (95.47M), greater than Unity Biotechnology, Inc. (38.00M), greater than Adaptimmune Therapeutics plc (101.47M), less than Mereo BioPharma Group plc (657.97M), greater than Pieris Pharmaceuticals, Inc. (1.60M), greater than PDS Biotechnology Corporation (79.68M), greater than Leap Therapeutics, Inc. (32.20M), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (1.15B), greater than Century Therapeutics, Inc. (154.70M), less than Blueprint Medicines Corporation (6.34B), less than Revolution Medicines, Inc. (7.17B), less than Sana Biotechnology, Inc. (914.15M), less than Kymera Therapeutics, Inc. (2.98B), greater than Monte Rosa Therapeutics, Inc. (300.68M),

Build a custom stock screener for Exscientia plc (EXAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exscientia plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exscientia plc (EXAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exscientia plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.